MetLife Investment Advisors »

Spyglass Pharma shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Spyglass Pharma (SGP) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $156k 7.0k 22.26

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm Bond (BSV)

View all positions for MetLife Investment Advisors

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
BlackRock
T. Rowe Price Associates
Vestal Point Capital
Jpmorgan Chase & Co
Deerfield Management Company
Millennium Management
Standard Life Aberdeen
Vanguard Capital Management
Geode Capital Management
Franklin Resources
Affinity Asset Advisors

View all funds holding Spyglass Pharma